Eccrine squamous syringometaplasia associated with Natalizumab
Dermatol Ther
.
2022 Jul;35(7):e15576.
doi: 10.1111/dth.15576.
Epub 2022 May 18.
Authors
Mariana Claudia Matei
1
,
Alba Navarro-Bielsa
1
,
Tamara Gracia-Cazaña
1
,
Isabel Abadías-Granado
2
,
Maria Carmen Gómez-Mateo
3
,
Yolanda Gilaberte
1
Affiliations
1
Dermatology Service. Hospital Miguel Servet, IIS Aragon. Zaragoza University, Zaragoza, Spain.
2
Department of Dermatology, Hospital de Barbastro, Huesca, Spain.
3
Pathological anatomy Service, Hospital Miguel Servet, Zaragoza, Spain.
PMID:
35581953
DOI:
10.1111/dth.15576
No abstract available
Publication types
Letter
MeSH terms
Carcinoma, Squamous Cell*
Eccrine Glands
Humans
Metaplasia
Natalizumab
Sweat Gland Neoplasms*
Substances
Natalizumab